MediMVB
0666.432.065 · rovalta.com · 22/09/2026
ACTIVE
MediMVB
Financial year 2025 · closed on 31/12/2025
Net result
15,9 k €
+535.0% YoY
Gross margin
57,9 k €
+21.4% YoY
Equity
122,5 k €
+14.1% YoY
Overview
What does MediMVB do?
MediMVB is a Private limited company incorporated in 2016. Its main activity is: Specialist medical practice activities. Its registered office is in Namur.
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0666.432.065
Incorporation
16/11/2016
Legal form
Private limited company
Registered office
Place Chapelle(SS) 6
5002 Namur · WallonieSee on map
5002 Namur · WallonieSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Activities (NACE)
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||
| Gross margin | 57,9 k € | +21.4% | 47,7 k € | -29.6% | 67,7 k € | +135% | 28,8 k € | -54.5% | 63,2 k € | +55.0% | 40,8 k € | -76.2% | 170,9 k € | +12.8% | 151,5 k € | -40.4% | 254,2 k € |
| EBITDA | 57,1 k € | +22.5% | 46,7 k € | -6.1% | 49,7 k € | +77.5% | 28 k € | -55.7% | 63,2 k € | +56.6% | 40,4 k € | -76.3% | 170,4 k € | +12.9% | 151 k € | -40.6% | 254 k € |
| Operating result | 52,1 k € | +221% | 16,2 k € | -64.5% | 45,7 k € | +83.6% | 24,9 k € | -58.1% | 59,5 k € | +64.3% | 36,2 k € | -77.8% | 163,3 k € | +15.3% | 141,7 k € | -41.1% | 240,4 k € |
| Net result | 15,9 k € | +535% | 2,5 k € | -92.3% | 32,5 k € | +148% | 13,1 k € | -69.0% | 42,2 k € | +49.1% | 28,3 k € | -66.4% | 84,2 k € | +40.3% | 60 k € | -61.4% | 155,5 k € |
| Balance sheet | |||||||||||||||||
| Equity | 122,5 k € | +14.1% | 107,4 k € | +1.6% | 105,7 k € | +42.7% | 74,1 k € | -76.9% | 321,1 k € | +8.1% | 296,9 k € | -6.2% | 316,6 k € | +42.8% | 221,7 k € | +37.1% | 161,7 k € |
| Total assets | 161,4 k € | +8.8% | 148,4 k € | +15.9% | 128 k € | -64.1% | 356,9 k € | -1.1% | 360,9 k € | -2.6% | 370,7 k € | +8.6% | 341,4 k € | +43.8% | 237,4 k € | +15.1% | 206,3 k € |
| Cash | 103,3 k € | +17.4% | 88 k € | +34.1% | 65,6 k € | -75.4% | 267 k € | -17.4% | 323,2 k € | +13.0% | 286 k € | +7.5% | 266,1 k € | +73.9% | 153 k € | +44.3% | 106 k € |
| Debts | 11,1 k € | -23.7% | 14,6 k € | -34.3% | 22,2 k € | -92.1% | 282,8 k € | +611% | 39,8 k € | -46.1% | 73,8 k € | +198% | 24,8 k € | +57.4% | 15,7 k € | -64.7% | 44,6 k € |
Estimate
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 2 active
Active mandates
GISELE MAURY
ActivePHILIPPE VAN BRUSSEL
ActiveAt this address
Other companies at this address
| Company | CBE no. |
|---|---|
| 0838.699.117 | |
JOAQUIM HALEN● Active | 1016.899.597 |
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 04/08/2026 | 14/07/2025 | 26/06/2024 | 31/07/2023 | 08/08/2022 | 21/06/2021 |
| General meeting | 30/06/2026 | 20/06/2025 | 13/06/2024 | 28/06/2023 | 28/06/2022 | 11/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
9 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 30/06/2026 | 04/08/2026 | French | |
| Micro model | 31/12/2024 | 20/06/2025 | 14/07/2025 | French | |
| Micro model | 31/12/2023 | 13/06/2024 | 26/06/2024 | French | |
| Micro model | 31/12/2022 | 28/06/2023 | 31/07/2023 | French | |
| Micro model | 31/12/2021 | 28/06/2022 | 08/08/2022 | French | |
| Micro model | 31/12/2020 | 11/06/2021 | 21/06/2021 | French | |
| Micro model | 31/12/2019 | 02/07/2020 | 26/08/2020 | French | |
| Micro model | 31/12/2018 | 30/06/2019 | 23/07/2019 | French | |
| Micro model | 31/12/2017 | 26/06/2018 | 31/07/2018 | French |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 2 active
Active mandates
GISELE MAURY
ActivePHILIPPE VAN BRUSSEL
ActiveShareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202515,9 k €↑
- 2024Annual accounts 20242,5 k €↓
- 2023Annual accounts 202332,5 k €↑
- 2023Name changeMedi MVB - PneuGenPrev
- 2022Annual accounts 202213,1 k €↓
- 2021Annual accounts 202142,2 k €↑
- 2020Annual accounts 202028,3 k €↓
- 2019Annual accounts 201984,2 k €↑
- 2018Annual accounts 201860 k €↓
- 2017Annual accounts 2017155,5 k €
- 2017Name changeMediMVB-PneuGenPrev
- 16/11/2016IncorporationPrivate limited company